New drug developed in Singapore could give eczema sufferers complete relief from symptoms

Around 13 per cent of Singapore's population suffers from eczema.
Around 13 per cent of Singapore's population suffers from eczema.PHOTO: ST FILE

SINGAPORE - A new drug currently being developed by local biotech company Aslan Pharmaceuticals may be able to provide those with eczema complete relief from their symptoms.

The company announced the enrolment of the first patient in its clinical trials on Tuesday (Oct 22).

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content